Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Nutrients 2012, 4(11), 1664-1678; doi:10.3390/nu4111664
Review

Insulinotropic and Muscle Protein Synthetic Effects of Branched-Chain Amino Acids: Potential Therapy for Type 2 Diabetes and Sarcopenia

1
, 2
, 3
 and 4,*
Received: 3 September 2012; in revised form: 29 October 2012 / Accepted: 1 November 2012 / Published: 8 November 2012
View Full-Text   |   Download PDF [470 KB, uploaded 8 November 2012]   |   Browse Figure
Abstract: The loss of muscle mass and strength with aging (i.e., sarcopenia) has a negative effect on functional independence and overall quality of life. One main contributing factor to sarcopenia is the reduced ability to increase skeletal muscle protein synthesis in response to habitual feeding, possibly due to a reduction in postprandial insulin release and an increase in insulin resistance. Branched-chain amino acids (BCAA), primarily leucine, increases the activation of pathways involved in muscle protein synthesis through insulin-dependent and independent mechanisms, which may help counteract the “anabolic resistance” to feeding in older adults. Leucine exhibits strong insulinotropic characteristics, which may increase amino acid availability for muscle protein synthesis, reduce muscle protein breakdown, and enhance glucose disposal to help maintain blood glucose homeostasis.
Keywords: amino acids; leucine; skeletal muscle; protein synthesis; insulin secretion amino acids; leucine; skeletal muscle; protein synthesis; insulin secretion
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Manders, R.J.; Little, J.P.; Forbes, S.C.; Candow, D.G. Insulinotropic and Muscle Protein Synthetic Effects of Branched-Chain Amino Acids: Potential Therapy for Type 2 Diabetes and Sarcopenia. Nutrients 2012, 4, 1664-1678.

AMA Style

Manders RJ, Little JP, Forbes SC, Candow DG. Insulinotropic and Muscle Protein Synthetic Effects of Branched-Chain Amino Acids: Potential Therapy for Type 2 Diabetes and Sarcopenia. Nutrients. 2012; 4(11):1664-1678.

Chicago/Turabian Style

Manders, Ralph J.; Little, Jonathan P.; Forbes, Scott C.; Candow, Darren G. 2012. "Insulinotropic and Muscle Protein Synthetic Effects of Branched-Chain Amino Acids: Potential Therapy for Type 2 Diabetes and Sarcopenia." Nutrients 4, no. 11: 1664-1678.



Nutrients EISSN 2072-6643 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert